CRISIS RESOURCES - #MEAction Network

CRISIS RESOURCES  #MEAction Network

Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Novel Orexin Re...

Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Novel Orexin Receptor Agonist E2086 for Narcolepsy  ACN Newswire

Vaccine Hesitancy Persists in Japan Despite Government Efforts - Unseen Japan

Vaccine Hesitancy Persists in Japan Despite Government Efforts  Unseen Japan

120,000 have been involuntarily institutionalized in Japan as of June 2024 - Japan Today

120,000 have been involuntarily institutionalized in Japan as of June 2024  Japan Today

日本人の年間出生数が初の70万人割れ、出生率も過去最低－24年 - Bloomberg.com

日本人の年間出生数が初の70万人割れ、出生率も過去最低－24年  Bloomberg.com

Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China - ACN News...

Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China  ACN Newswire

資料6－A - mhlw.go.jp

資料6－A  mhlw.go.jp

Late-life divorce rate hits record high as elderly population rises - 朝日新聞

Late-life divorce rate hits record high as elderly population rises  朝日新聞

Matchmaking Party Promoted by Tokyo Rejects Disabled Man - Unseen Japan

Matchmaking Party Promoted by Tokyo Rejects Disabled Man  Unseen Japan

Revenue of LEQEMBI(R) (Preliminary Basis) - ACN Newswire

Revenue of LEQEMBI(R) (Preliminary Basis)  ACN Newswire

As Japan’s Birth Rate Dwindles, Its Nursery Schools Keep Closing - Unseen Japan

As Japan’s Birth Rate Dwindles, Its Nursery Schools Keep Closing  Unseen Japan

LEQEMBI Wins Best New Drug And Clinical Advance of The Year at The Scrip Awards 2023 - ACN Newswire

LEQEMBI Wins Best New Drug And Clinical Advance of The Year at The Scrip Awards 2023  ACN Newswire

Could Japan Become Anti-Child as Population Declines? - Unseen Japan

Could Japan Become Anti-Child as Population Declines?  Unseen Japan

Eisai to Divest Rights for Anti-Epileptic Drug Fycompa (perampanel) CIII in United States to Cata...

Eisai to Divest Rights for Anti-Epileptic Drug Fycompa (perampanel) CIII in United States to Catalyst Pharmaceuticals  ACN Newswire

Amyotrophic Lateral Sclerosis Treatment "Rozebalamin(R) for Injection 25 mg" Receives The Good De...

Amyotrophic Lateral Sclerosis Treatment "Rozebalamin(R) for Injection 25 mg" Receives The Good Design Award 2024 for Light- Proof Vial Packaging  ACN Newswire

Eisai: Update on the Co-Promotion of the Oral Antifungal Agent Nailin Capsules 100mg in Japan - A...

Eisai: Update on the Co-Promotion of the Oral Antifungal Agent Nailin Capsules 100mg in Japan  ACN Newswire

Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Tr...

Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Designated for Priority Review in China  ACN Newswire

New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China - ACN ...

New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China  ACN Newswire

New NEURii Research Collaboration Between Eisai, Gates Ventures, Health Data Research UK, Lifearc...

New NEURii Research Collaboration Between Eisai, Gates Ventures, Health Data Research UK, Lifearc and The University of Edinburgh to Develop Digital Solutions for Dementia is Announced  ACN Newswire

Eisai: Joint Development Agreement Aiming for Drug Discovery for COVID-19 Utilizing Eritoran and ...

Eisai: Joint Development Agreement Aiming for Drug Discovery for COVID-19 Utilizing Eritoran and E6011 Concluded  ACN Newswire

Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary T...

Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements  ACN Newswire

Information for Adverse Events｜Ministry of Health, Labour and Welfare - mhlw.go.jp

Information for Adverse Events｜Ministry of Health, Labour and Welfare  mhlw.go.jp

Japan Bans Cannabis Gummies After Multiple Hospitalizations - Unseen Japan

Japan Bans Cannabis Gummies After Multiple Hospitalizations  Unseen Japan

Death by Overwork in Japan: Cultivating a Healthy Workforce From Across the World - The National ...

Death by Overwork in Japan: Cultivating a Healthy Workforce From Across the World  The National Law Review

外国人労働者数が初の200万人超え、人手不足解消へ強まる依存 - Bloomberg.com

外国人労働者数が初の200万人超え、人手不足解消へ強まる依存  Bloomberg.com

"Urece Tablets" (Dotinurad) Approved In Thailand For Gout And Hyperuricemia - ACN Newswire

"Urece Tablets" (Dotinurad) Approved In Thailand For Gout And Hyperuricemia  ACN Newswire

Eisai to Launch In-House Developed New Anti-insomnia Drug Dayvigo (Lemborexant) with Indication f...

Eisai to Launch In-House Developed New Anti-insomnia Drug Dayvigo (Lemborexant) with Indication for Insomnia in Japan  ACN Newswire

Eisai: MOVICOL Launched in Japan - ACN Newswire

Eisai: MOVICOL Launched in Japan  ACN Newswire

Eisai to Take over Manufacturing and Marketing Approval for Equfina 50mg Tablets (Safinamide Mesi...

Eisai to Take over Manufacturing and Marketing Approval for Equfina 50mg Tablets (Safinamide Mesilate) in Japan from Meiji Seika Pharma  ACN Newswire

ＧＰＩＦの実質運用利回り引き上げへ、1.9％案を提示－厚労省審議会 - Bloomberg.com

ＧＰＩＦの実質運用利回り引き上げへ、1.9％案を提示－厚労省審議会  Bloomberg.com

Giving back to welfare: A young hero at a support facility for people with disabilities - 朝日新聞

Giving back to welfare: A young hero at a support facility for people with disabilities  朝日新聞

Japan To Give Out Coupons for New Moms - Unseen Japan

Japan To Give Out Coupons for New Moms  Unseen Japan

Japanese Women Just Want to Be Able to Wear Comfortable Shoes to Work - The Cut

Japanese Women Just Want to Be Able to Wear Comfortable Shoes to Work  The Cut

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symp...

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium  ACN Newswire

Water Supply - Ministry of Health, Labour and Welfare - mhlw.go.jp

Water Supply - Ministry of Health, Labour and Welfare  mhlw.go.jp

What is the trending “parallel career” work style that can transform the sheltered care industry?...

What is the trending “parallel career” work style that can transform the sheltered care industry?  朝日新聞

Eisai to Launch "Chocola BB Gold Rich" Highest Combination of Active Ingredients in Chocola BB Se...

Eisai to Launch "Chocola BB Gold Rich" Highest Combination of Active Ingredients in Chocola BB Series  ACN Newswire

Launch of Pain Treatment Lyrica OD Tablet Formulation in Japan - ACN Newswire

Launch of Pain Treatment Lyrica OD Tablet Formulation in Japan  ACN Newswire

Eisai Commences Business Activities at New Pharma Sales Subsidiary in Israel - ACN Newswire

Eisai Commences Business Activities at New Pharma Sales Subsidiary in Israel  ACN Newswire

"Fatigue Recovery While You Sleep!" Eisai to Launch Designated Quasi-Drug Drink "Chocola BB Night...

"Fatigue Recovery While You Sleep!" Eisai to Launch Designated Quasi-Drug Drink "Chocola BB Nightwell"  ACN Newswire

A look at the kanji that helps us turn nouns into adjectives - The Japan Times

A look at the kanji that helps us turn nouns into adjectives  The Japan Times

With #KuToo, Japanese women fight back against high heels in the workplace - The Observers - Fran...

With #KuToo, Japanese women fight back against high heels in the workplace  The Observers - France 24

COVID-19-related travel restrictions between Japan and U.S., Europe and Australia (As of May 7 20...

COVID-19-related travel restrictions between Japan and U.S., Europe and Australia (As of May 7 2020)  トラベルボイス｜観光産業ニュース